R

ReCor Medical

Renal denervation system using ultrasound

Therapy Development Territory Manager

Field SalesConfirmed live in the last 24 hours
Full-timeCalifornia, USA$120k - $150k /yr

About the Job

Requirements

  • A bachelor's degree and 5+ years of sales experience, including 2+ years of experience in a clinical or healthcare/pharmaceutical sales environment.
  • Existing relationships within the geographic area with primary care, cardiology, nephrology, or other hypertension management offices, or direct knowledge of physicians and clinicians in the therapy market.
  • Candidates must reside in the listed territory.
  • The role may require up to 50% travel.

Responsibilities

  • Determine where the company's therapies can assist in providing an adjunctive hypertension management solution.
  • Identify key referral networks for renal denervation therapy across multiple provider types.
  • Develop and enhance relationships through therapy awareness activities, routine customer visits, product demonstrations, educational programs, procedural observation, trade show participation, and problem resolution.
  • Educate physicians and advanced healthcare practitioners on the merits and proper incorporation of company products through presentations and demonstrations.
  • Work closely with Territory Management and Clinical Site Management in evaluating patient care pathway conditions.
  • Identify shared priorities and leverage knowledge and tactics within the full account to develop a strategic territory business plan that drives product demand by meeting the needs of key partners and their patients.
  • Analyze existing referral trends to gain insights into the local healthcare network, drive pull-through, and lead virtual or live customer engagements.

About the Company

ReCor Medical

Renal denervation system using ultrasound

ReCor Medical develops the Paradise System, a renal denervation platform that uses non-focused ultrasound to treat hypertension. The device delivers ultrasound energy to the kidney region to disrupt renal nerves, aiming to lower blood pressure in patients whose hypertension does not respond well to traditional medications. Unlike catheter-based or chemical denervation methods, it emphasizes a non-invasive ultrasound approach and supports its use with multicenter clinical trials (such as the RADIANCE program) to obtain regulatory approvals. The company's goal is to provide a durable, safe method to lower blood pressure and achieve broad adoption of its device in the global healthcare market.

Company size
201-500
Company stage
Debt Financing
Total funding
$40M
Headquarters
Palo Alto, CA
Founded
2009

Recently Posted Jobs

Explore more opportunities at ReCor Medical

See more jobs